Dynamic Technology Lab Private LTD Tricida, Inc. Transaction History

Dynamic Technology Lab Private LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.56 - $4.64 $51,563 - $67,205	-14,484 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.95 - $5.41 $57,211 - $78,358	14,484 New	14,484 $62,000
Q1 2021 May 14, 2021	SELL	$4.52 - $7.8 $74,313 - $128,239	-16,441 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$4.37 - $9.46 $14,005 - $30,319	-3,205 Reduced 16.31%	16,441 $116,000
Q3 2020 Nov 13, 2020	BUY	$8.56 - $26.93 $168,169 - $529,066	19,646 New	19,646 $178,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.